Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging

Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor

Leukemia, Monocytic, Acute Clinical Trial

Official title:
Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor

See also
	Status	Clinical Trial	Phase
	Withdrawn	`NCT02527174` - A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia	Phase 1
	Recruiting	`NCT05313958` - Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children	Phase 2/Phase 3

See also

Status

Clinical Trial

Phase

Withdrawn

NCT02527174 - A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia

Phase 1

Recruiting

NCT05313958 - Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children

Phase 2/Phase 3

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00531583
Study type	Interventional
Source	King Faisal Specialist Hospital & Research Center
Contact
Status	Completed
Phase	N/A
Start date	March 2001
Completion date	June 2015

Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms